Technical Analysis for EXAS - Exact Sciences Corporation

Grade Last Price % Change Price Change
grade A 74.97 -2.75% -2.12
EXAS closed down 2.75 percent on Wednesday, January 16, 2019, on 78 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical EXAS trend table...

Date Alert Name Type % Chg
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Overbought Stochastic Strength 0.00%
Jan 15 Wide Bands Range Expansion -2.75%
Jan 15 Overbought Stochastic Strength -2.75%
Jan 14 Calm After Storm Range Contraction 1.89%
Jan 14 Wide Bands Range Expansion 1.89%
Jan 14 Overbought Stochastic Strength 1.89%
Jan 14 Gapped Down Weakness 1.89%
Jan 11 Stochastic Sell Signal Bearish -1.85%
Jan 11 Calm After Storm Range Contraction -1.85%

Older signals for EXAS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing diagnostic screening products for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect pre-cancerous lesions or polyps, and each of the four stages of colorectal cancer. Its Cologuard test includes proprietary and patented methods that isolate and analyze the human DNA that are shed into stool every day from the exfoliation of cells that line the colon; and also protein marker to detect blood in the stool, utilizing an antibody-based fecal immunochemical test. The company's stool-based DNA colorectal cancer screening technology also focuses on the inflammatory bowel disease. It has collaboration, license, and purchase agreement with Genzyme Corporation, as well as with Mayo Clinic for developing tests to detect other gastro-intestinal cancers, primarily esophageal and pancreatic cancer. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Is EXAS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 82.85
52 Week Low 37.36
Average Volume 1,712,586
200-Day Moving Average 63.1927
50-Day Moving Average 69.9856
20-Day Moving Average 67.4445
10-Day Moving Average 73.702
Average True Range 4.0293
ADX 21.62
+DI 30.3949
-DI 19.094
Chandelier Exit (Long, 3 ATRs ) 66.8621
Chandelier Exit (Short, 3 ATRs ) 65.1479
Upper Bollinger Band 82.7771
Lower Bollinger Band 52.1119
Percent B (%b) 0.75
BandWidth 45.46731
MACD Line 2.3371
MACD Signal Line 1.0246
MACD Histogram 1.3125
Fundamentals Value
Market Cap 8.92 Billion
Num Shares 119 Million
EPS -1.29
Price-to-Earnings (P/E) Ratio -58.12
Price-to-Sales 34.69
Price-to-Book 10.86
PEG Ratio -1.87
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 80.08
Resistance 3 (R3) 80.57 79.37 79.23
Resistance 2 (R2) 79.37 78.07 79.12 78.94
Resistance 1 (R1) 77.17 77.26 76.57 76.67 78.66
Pivot Point 75.96 75.96 75.66 75.71 75.96
Support 1 (S1) 73.76 74.66 73.16 73.27 71.28
Support 2 (S2) 72.56 73.86 72.31 71.00
Support 3 (S3) 70.36 72.56 70.71
Support 4 (S4) 69.86